Stay updated on Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial

Sign up to get notified when there's something new on the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added the term Non-immunoglobulin-mediated membranoproliferative glomerulonephritis under the conditions and a Resources section linking Genetic and Rare Diseases Information Center; the page revision was updated to v3.4.2. Removed the government funding notice and the prior revision note v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T12:15:21.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a global notice about potential delays due to a lapse in government funding. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:28:42.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Show glossary has been added to the page, and the footer now displays 'Last Update Submitted that Met QC Criteria' along with 'Revision: v3.4.0'. The previous labels and data—'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'—have been removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:17:13.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows a minor revision from v3.3.3 to v3.3.4 with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:49:32.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    New 'Locations' section lists trial sites across the United States (Arizona, California, Colorado, Minnesota, Missouri, New York) and international sites (Buenos Aires, Victoria, Rio Grande do Sul, São Paulo). This expands visibility of where the study is conducted and improves access for potential participants.
    Difference
    1%
    Check dated 2025-12-23T21:08:17.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.2.0 to v3.3.2. No changes to study details, eligibility criteria, or page navigation are visible.
    Difference
    0.0%
    Check dated 2025-11-25T14:47:25.000Z thumbnail image

Stay in the know with updates to Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page.